Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -31.62% is 59% above its 5-year average of -76.86%, near the high end of its 5-year range (-215.00%–6.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 51.51% above its 12-month average of -65.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -31.62%.
RETURN ON INVESTED CAPITAL (ROIC)
-31.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-65.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-89.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-76.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+51.51%
CURRENT VS 3Y AVG
+64.58%
CURRENT VS 5Y AVG
+58.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
+8.17%
vs the sector median at left
SAB Biotherapeutics, Inc.
Market Cap
$276.14M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-65.21%
3Y Avg
-89.27%
5Y Avg
-76.86%
Market Cap
$273.33M
Return on Invested Capital (ROIC)
-58.72%
TTM Avg
-52.25%
3Y Avg
-49.23%
5Y Avg
-41.07%
Market Cap
$280.29M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-4.06%
3Y Avg
-9.73%
5Y Avg
-12.88%
Market Cap
$271.90M
Return on Invested Capital (ROIC)
-48.92%
TTM Avg
-66.11%
3Y Avg
-56.53%
5Y Avg
-47.58%
Market Cap
$269.92M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$282.68M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
Market Cap
$283.87M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$267.03M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$266.50M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | $276.14M | -31.62% | -65.21% | -89.27% | -76.86% |
| Fate Therapeutics, Inc. (FATE)vs › | $273.33M | -58.72% | -52.25% | -49.23% | -41.07% |
| Aurora Cannabis Inc. (ACB)vs › | $280.29M | -15.69% | -4.06% | -9.73% | -12.88% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $271.90M | -48.92% | -66.11% | -56.53% | -47.58% |
| Scribe Therapeutics Inc. (SCTX)vs › | $269.92M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | -27.62% | -16.38% | -32.77% | -39.71% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.87M | -61.10% | -38.45% | -31.16% | -81.63% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | -170.19% | -56.97% | -50.85% | -45.83% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.50M | -43.56% | -66.27% | -114.94% | -104.61% |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.83M | -49.76% | -54.76% | -73.23% | -84.98% |
ROIC
-31.6%
ROE
-6.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -31.62% |
| 2026-03-31 | -24.38% |
| 2025-12-31 | -30.02% |
| 2025-09-30 | -25.02% |
| 2025-06-30 | -215.00% |
| 2025-03-31 | -147.85% |
| 2024-12-31 | -117.59% |
| 2024-09-30 | -113.78% |
| 2024-06-30 | -83.32% |
| 2024-03-31 | -65.83% |
| 2023-12-31 | -51.33% |
| 2023-09-30 | -137.60% |
| 2023-06-30 | -117.17% |
| 2023-03-31 | -100.55% |
| 2022-12-31 | -78.83% |
| 2022-09-30 | -80.22% |
| 2022-06-30 | -57.15% |
| 2022-03-31 | -42.49% |
| 2021-12-31 | -23.71% |
| 2021-09-30 | 6.23% |
